Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Sales: 2021-2025

Historic Return on Sales for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Sep 2025 value amounting to -0.09%.

  • Mirum Pharmaceuticals' Return on Sales rose 24.00% to -0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.09%, marking a year-over-year increase of 24.00%. This contributed to the annual value of -0.26% for FY2024, which is 62.00% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Return on Sales of -0.09% as of Q3 2025, which was up 35.66% from -0.14% recorded in Q2 2025.
  • Mirum Pharmaceuticals' Return on Sales' 5-year high stood at -0.09% during Q3 2025, with a 5-year trough of -14.56% in Q3 2021.
  • Its 3-year average for Return on Sales is -0.64%, with a median of -0.41% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 1,376bps in 2022, then crashed by 33bps in 2023.
  • Mirum Pharmaceuticals' Return on Sales (Quarterly) stood at -5.35% in 2021, then surged by 359bps to -1.76% in 2022, then skyrocketed by 88bps to -0.88% in 2023, then surged by 62bps to -0.26% in 2024, then rose by 24bps to -0.09% in 2025.
  • Its last three reported values are -0.09% in Q3 2025, -0.14% for Q2 2025, and -0.20% during Q1 2025.